🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be an open-label, non-randomized, absorption, metabolism, a...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01474668
Treatments Being Tested
This Phase 1, open-label, randomized, 4-period crossover study is designed ...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02092831
This is a Phase I, randomized, two-part, single-center pharmacokinetics (PK...
Status
Completed
Location
Genentech Trial Information Support
Start Date
2009-10-26
Trial ID
NCT00999128
Treatments Being Tested
This is an open-label, multicenter, Phase Ib dose-escalation study to asses...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00975182
Treatments Being Tested
This is an open-label, Phase I, dose-escalation study using a 3 + 3 design ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00876122
Treatments Being Tested
Part A: This is a phase Ib trial combining the CDK4/6 inhibitor palbociclib...
Status
Completed
Location
The Royal Marsden NHS Foundation Trust
Start Date
2015-03-25
Trial ID
NCT02389842
Treatments Being Tested
It is known that after application of MK-3475 activated PD -1 negatively re...
Status
Unknown
Location
Dana-Farber Cancer Institute
Start Date
2013-03
Trial ID
NCT02430363
Treatments Being Tested
This is an open-label, multicenter, Phase I, dose-escalation study to asses...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00876109
Treatments Being Tested
This phase I/II trial study evaluates the tolerability and best tolerated d...
Status
Terminated
Location
University of Alabama
Start Date
2013-09
Trial ID
NCT01918306
This is an open-label, multicenter, Phase Ib dose-escalation study to asses...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT00974584
Treatments Being Tested